Literature DB >> 33141500

Genetic control of tumor development in malformation syndromes.

Floor A M Postema1, Jan C Oosterwijk2, Raoul C Hennekam1.   

Abstract

One of the questions that arises frequently when caring for an individual with a malformation syndrome, is whether some form of tumor surveillance is indicated. In some syndromes there is a highly variable increased risk to develop tumors, while in others this is not the case. The risks can be hard to predict and difficult to explain to affected individuals and their families, and often also to caregivers. The queries arise especially if syndrome causing mutations are also known to occur in tumors. It needs insight in the mechanisms to understand and explain differences of tumor occurrence, and to offer optimal care to individuals with syndromes. Here we provide a short overview of the major mechanisms of the control for tumor occurrences in malformation syndromes.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  CNVs; cancer; epigenetics; genetic compensation; mosaicism; tumor predisposition syndrome

Mesh:

Year:  2020        PMID: 33141500     DOI: 10.1002/ajmg.a.61947

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

1.  Molecular characterization of an embryonal rhabdomyosarcoma occurring in a patient with Kabuki syndrome: report and literature review in the light of tumor predisposition syndromes.

Authors:  Sietse M Aukema; Selina Glaser; Mari F C M van den Hout; Sonja Dahlum; Marinus J Blok; Morten Hillmer; Julia Kolarova; Raf Sciot; Dina A Schott; Reiner Siebert; Constance T R M Stumpel
Journal:  Fam Cancer       Date:  2022-07-19       Impact factor: 2.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.